Stokes Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Stokes Capital Advisors's AMGN Position: Q2 2026 in Review
Stokes Capital Advisors increased its Amgen (AMGN) stake by 33% in Q2 2026, buying an estimated $258K and bringing the position to 3,061 shares worth $1.11M. The position accounts for 0.24% of the portfolio, ranked #63.
Stokes Capital Advisors first reported a position in AMGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $2.51M in Q1 2019. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Stokes Capital Advisors held 3,061 shares of Amgen worth $1.11M as of Q2 2026.
- Stokes Capital Advisors bought 755 Amgen shares in Q2 2026, an estimated $258K.
- Amgen made up 0.24% of Stokes Capital Advisors's portfolio in Q2 2026, its #63 holding.
- Stokes Capital Advisors first reported a position in Amgen in Q4 2017 and has held it in 20 quarters since.
- Stokes Capital Advisors's Amgen position peaked at $2.51M in Q1 2019.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Stokes Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.